Search

Search Constraints

You searched for: Author/Creator Kuhnast, Bertrand

Search Results

1. [18F]DPA‐C5yne, a novel fluorine‐18‐labelled analogue of DPA‐714: radiosynthesis and preliminary evaluation as a radiotracer for imaging neuroinflammation with PET. (24th April 2014)

3. Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies. Issue 1 (16th April 2019)

4. Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies. Issue 1 (16th April 2019)

5. Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43–50]. (1st August 2019)

6. Differential influence of propofol and isoflurane anesthesia in a non‐human primate on the brain kinetics and binding of [18F]DPA‐714, a positron emission tomography imaging marker of glial activation. (22nd June 2015)

7. Differential influence of propofol and isoflurane anesthesia in a non‐human primate on the brain kinetics and binding of [18F]DPA‐714, a positron emission tomography imaging marker of glial activation. (22nd June 2015)

8. Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal. (1st January 2017)

9. Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using 18F‐DPA‐714. (25th September 2017)

10. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. (January 2021)